BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30573372)

  • 21. The degree of integration of non-dispensing pharmacists in primary care practice and the impact on health outcomes: A systematic review.
    Hazen ACM; de Bont AA; Boelman L; Zwart DLM; de Gier JJ; de Wit NJ; Bouvy ML
    Res Social Adm Pharm; 2018 Mar; 14(3):228-240. PubMed ID: 28506574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishing pathways for access to pharmacist-provided patient care.
    Schommer JC; Doucette WR; Planas LG
    J Am Pharm Assoc (2003); 2015; 55(6):664-668. PubMed ID: 26547600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future of health-system pharmacy: opportunities and challenges in practice model change.
    Zellmer WA
    Ann Pharmacother; 2012 Apr; 46(4):S41-5. PubMed ID: 22499740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of a pharmacist in improving quality measures that affect payments to physicians.
    Sinclair J; Bentley OS; Abubakar A; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S85-S90. PubMed ID: 31203017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The paradox of pharmacy: A profession's house divided.
    Brown D
    J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacy's journey toward the patient-centered medical home.
    Erickson S; Hambleton J
    J Am Pharm Assoc (2003); 2011; 51(2):156-60. PubMed ID: 21382804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating pharmacists into primary care teams: barriers and facilitators.
    Jorgenson D; Laubscher T; Lyons B; Palmer R
    Int J Pharm Pract; 2014 Aug; 22(4):292-9. PubMed ID: 24279947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost Effectiveness of Advanced Pharmacy Services Provided in the Community and Primary Care Settings: A Systematic Review.
    Dawoud DM; Haines A; Wonderling D; Ashe J; Hill J; Varia M; Dyer P; Bion J
    Pharmacoeconomics; 2019 Oct; 37(10):1241-1260. PubMed ID: 31179514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The I-Tribe Community Pharmacy Practice Model: professional pharmacy unshackled.
    Alston GL; Waitzman JA
    J Am Pharm Assoc (2003); 2013; 53(2):163-71. PubMed ID: 23571624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating pharmacists into diverse diabetes care teams: implementation tactics from Project IMPACT: Diabetes.
    Watson LL; Bluml BM
    J Am Pharm Assoc (2003); 2014; 54(5):538-41. PubMed ID: 25216884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical networks influencing policy and practice: the establishment of advanced practice pharmacist roles for specialist palliative care services in South Australia.
    Swetenham K; Rowett D; Stephenson D
    Aust Health Rev; 2014 May; 38(2):238-41. PubMed ID: 24670916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas.
    Wong SL; Barner JC; Sucic K; Nguyen M; Rascati KL
    J Am Pharm Assoc (2003); 2017; 57(3):375-381. PubMed ID: 28506398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to facilitate the implementation of collaborative practice agreements in chain community pharmacies.
    Bacci JL; Coley KC; McGrath K; Abraham O; Adams AJ; McGivney MS
    J Am Pharm Assoc (2003); 2016; 56(3):257-265.e2. PubMed ID: 27053276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacist, physician, and patient opinions of pharmacist-treated minor ailments and conditions.
    McKeirnan KC; Garrelts MacLean L
    J Am Pharm Assoc (2003); 2018; 58(6):599-607. PubMed ID: 30266565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of chronic disease management algorithms in Australian community pharmacies.
    Morrissey H; Ball P; Jackson D; Pilloto L; Nielsen S
    Res Social Adm Pharm; 2015; 11(2):176-96. PubMed ID: 25035062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
    Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
    Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacy and primary care perspectives on e-prescribing in a rural community: A focused ethnography.
    Kooienga S; Singh RL
    Res Social Adm Pharm; 2017; 13(4):820-830. PubMed ID: 27624860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of Community Pharmacists in Transition of Care (TOC) Services: Current Trends and Pharmacist Perceptions.
    Zeleznikar EA; Kroehl ME; Perica KM; Thompson AM; Trinkley KE
    J Pharm Pract; 2019 Feb; 32(1):28-35. PubMed ID: 29061080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medication management for community palliative care patients and the role of a specialist palliative care pharmacist: A qualitative exploration of consumer and health care professional perspectives.
    Kuruvilla L; Weeks G; Eastman P; George J
    Palliat Med; 2018 Sep; 32(8):1369-1377. PubMed ID: 29793391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.